Parmax Pharma Ltd — Board Meeting, 30-05-2025: Board Meeting

Parmax Pharma Limited has announced a board meeting regarding the financial results for the quarter and half-year. The company reported revenue from operations of Rs. 4.83 Cr for the quarter and Rs. 28.20 Cr for the year, but incurred a net loss of Rs. 1.49 Cr for the quarter and Rs. 2.09 Cr for the year. The loss was impacted by a fire incident at its manufacturing facility causing asset damage, accounted as Rs. 3.69 Cr under current assets, with insurance claim recovery yet to be finalized. Total assets increased to Rs. 187.52 Cr, supported by higher borrowings. Cash flow remained tight with negative operating and investing cash flows, partially offset by increased borrowings. The auditors issued an unqualified opinion but flagged the fire loss provision and an investment made in the Managing Director's name as key notes for investors.